Expression analysis of serum microRNAs in idiopathic pulmonary fibrosis

International Journal of Molecular Medicine

Volumn 33, Issue 6, 2014, Pages 1554-1562

  Li, Ping ^a   Li, Juan ^a   Chen, Tengfei ^a   Wang, Huaqi ^a   Chu, Heying ^a   Chang, Jingxia ^a   Zang, Wenqiao ^a   Wang, Yuanyuan ^a   Ma, Yunyun ^a   Du, Yuwen ^a   Zhao, Guoqiang ^a   Zhang, Guojun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Idiopathic pulmonary fibrosis; Microarray; Quantitative reverse transcription polymerase chain reaction; Serum microRNA

Indexed keywords

MICRORNA; MICRORNA 155; MICRORNA 21; MIR 101 3P; UNCLASSIFIED DRUG; MIRN101 MICRORNA, HUMAN; MIRN155 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; GENETICS; PHYSIOLOGY; VITAL CAPACITY;

FEMALE; GENE EXPRESSION PROFILING; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VITAL CAPACITY;

EID: 84899531719     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1712     Document Type: Article

References (31)

1. Maher TM, Wells AU and Laurent GJ: Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J 30: 835-839, 2007. (Pubitemid 351194784)
2. Fernández Pérez ER, Daniels CE, Schroeder DR, St Sauver J, Hartman TE, Bartholmai BJ, Yi ES and Ryu JH: Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest 137: 129-137, 2010.
3. Navaratnam V, Fleming KM, West J, Smith CJ, Jenkins RG, Fogarty A and Hubbard RB: The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax 66: 462-467, 2011.
4. Nalysnyk L, Cid-Ruzafa J, Rotella P and Esser D: Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev 21: 355-361, 2012.
5. Ley B, Collard HR and King TE Jr: Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183: 431-440, 2011.
6. Yokoyama A, Kondo K, Nakajima M, Matsushima T, Takahashi T, Nishimura M, Bando M, Sugiyama Y, Totani Y, Ishizaki T, Ichiyasu H, Suga M, Hamada H and Kohno N: Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 11: 164-168, 2006. (Pubitemid 43356896)
7. Prasse A, Probst C, Bargagli E, Zissel G, Toews GB, Flaherty KR, Olschewski M, Rottoli P and Muller-Quernheim J: Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179: 717-723, 2009.
8. Kinder BW, Brown KK, McCormack FX, Ix JH, Kervitsky A, Schwarz MI and King TE Jr: Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 135: 1557-1563, 2009.
9. Rosas IO, Richards TJ, Konishi K, Zhang Y, Gibson K, Lokshin AE, Lindell KO, Cisneros J, Macdonald SD, Pardo A, Sciurba F, Dauber J, Selman M, Gochuico BR and Kaminski N: MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 5: e93, 2008.
10. Lin KY, Zhang XJ, Feng DD, Zhang H, Zeng CW, Han BW, Zhou AD, Qu LH, Xu L and Chen YQ: miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies. J Biol Chem 286: 38253-38263, 2011.
11. Han BW, Feng DD, Li ZG, Luo XQ, Zhang H, Li XJ, Zhang XJ, Zheng LL, Zeng CW, Lin KY, Zhang P, Xu L and Chen YQ: A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. Hum Mol Genet 20: 4903-4915, 2011.
12. Hwang MS, Yu N, Stinson SY, Yue P, Newman RJ, Allan BB and Dornan D: miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to- mesenchymal transition in breast cancer. PLoS One 8: e66502, 2013.
13. Paterson EL, Kazenwadel J, Bert AG, Khew-Goodall Y, Ruszkiewicz A and Goodall GJ: Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression. Neoplasia 15: 180-191, 2013.
14. Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL and Shen CY: MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Res Treat 134: 1081-1093, 2012.
15. Bala S, Tilahun Y, Taha O, Alao H, Kodys K, Catalano D and Szabo G: Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J Transl Med 10: 151, 2012.
16. van der Meer AJ, Farid WR, Sonneveld MJ, de Ruiter PE, Boonstra A, van Vuuren AJ, Verheij J, Hansen BE, de Knegt RJ, van der Laan LJ and Janssen HL: Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122. J Viral Hepat 20: 158-166, 2013.
17. Haghikia A, Haghikia A, Hellwig K, Baraniskin A, Holzmann A, Décard BF, Thum T and Gold R: Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study. Neurology 79: 2166-2170, 2012.
18. Mitchell PS1, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB and Tewari M: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
19. Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, Hu Z, Zhuang R, Ning G, Zhang C, Yuan Y, Li Z, Zen K, Ba Y and Zhang CY: Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 58: 610-618, 2012.
20. Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY and Zhang C: Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer 132: 116-127, 2013.
21. Li P, Zhao GQ, Chen TF, Chang JX, Wang HQ, Chen SS and Zhang GJ: Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis. J Asthma 50: 960-964, 2013.
22. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108, 2008. (Pubitemid 351818697)
23. Raghu G, Collard HR, Egan JJ, et al: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183: 788-824, 2011.
24. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS and Harris AL: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675, 2008. (Pubitemid 351667616)
25. Zheng H, Zhang L, Zhao Y, Yang D, Song F, Wen Y, Hao Q, Hu Z, Zhang W and Chen K: Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer. PLoS One 8: e77853, 2013.
26. Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, Zhou JH and Zhang YK: High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 29: 618-626, 2012.
27. Wang Y, Gu J, Roth JA, Hildebrandt MA, Lippman SM, Ye Y, Minna JD and Wu X: Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer. Cancer Res 73: 4801-4809, 2013.
28. Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L, Huang D, Tan C, Sheng W and Du X: Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One 7: e44398, 2012.
29. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD and Glaab WE: Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55: 1977-1983, 2009.
30. Tryndyak VP, Latendresse JR, Montgomery B, Ross SA, Beland FA, Rusyn I and Pogribny IP: Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet. Toxicol Appl Pharmacol 262: 52-59, 2012.
31. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N and Abraham E: miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207: 1589-1597, 2010.